HFS
TXG icon

Hantz Financial Services’s 10x Genomics TXG Stock Holding History

Hantz Financial Services’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Hold
23
– – ﹤0.01% 2418
2026
Q1 		$0 Hold
23
– – ﹤0.01% 2609
2025
Q4 		$0 Hold
23
– – ﹤0.01% 2535
2025
Q3 		$0 Hold
23
– – ﹤0.01% 2450
2025
Q2 		$0 Buy
+23
New +$210 ﹤0.01% 2302

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hantz Financial Services's TXG Position: Q2 2026 in Review

Hantz Financial Services held its 10x Genomics (TXG) position steady in Q2 2026 at 23 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2418.

Hantz Financial Services first reported a position in TXG in Q2 2025 and has held it in 5 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Hantz Financial Services held 23 shares of 10x Genomics worth $1K as of Q2 2026.
  • Hantz Financial Services left its 10x Genomics share count unchanged in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #2418 holding.
  • Hantz Financial Services first reported a position in 10x Genomics in Q2 2025 and has held it in 5 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.